Latest Ratios: P/E Ratio 41.1x · EV/EBITDA N/A · ROE 4.7%. (2021–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| Market Cap | $154M | $207M | — | — |
| Enterprise Value | $153M | $206M | — | — |
| P/E Ratio → | 41.05 | 60.12 | — | — |
| P/S Ratio | — | — | — | — |
| P/B Ratio | 1.51 | 1.45 | — | — |
| P/FCF | — | — | — | — |
| P/OCF | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| EV / Revenue | — | — | — | — |
| EV / EBITDA | — | — | — | — |
| EV / EBIT | — | — | — | — |
| EV / FCF | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| Gross Margin | — | — | — | — |
| Operating Margin | — | — | — | — |
| Net Profit Margin | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| ROE | 4.7% | 4.7% | — | 12.8% |
| ROA | 4.5% | 4.5% | -44.2% | 11.4% |
| ROIC | -0.5% | -0.5% | — | -0.5% |
| ROCE | -0.6% | -0.6% | — | -0.6% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| Debt / Equity | — | — | — | 0.00 |
| Debt / EBITDA | — | — | — | 0.01 |
| Net Debt / Equity | — | -0.00 | — | 0.00 |
| Net Debt / EBITDA | — | — | — | 0.01 |
| Debt / FCF | — | — | — | — |
| Interest Coverage | — | — | — | — |
Net cash position: cash ($365751) exceeds total debt ($0)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| Current Ratio | 3.97 | 3.97 | 0.15 | 0.22 |
| Quick Ratio | 3.97 | 3.97 | 0.15 | 0.22 |
| Cash Ratio | 3.75 | 3.75 | 0.15 | 0.02 |
| Asset Turnover | — | — | — | — |
| Inventory Turnover | — | — | — | — |
| Days Sales Outstanding | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| Dividend Yield | — | — | — | — |
| Payout Ratio | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2021 |
|---|---|---|---|---|
| Earnings Yield | 2.4% | 1.7% | — | — |
| FCF Yield | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $20M | $18M | $58M |
Includes 30+ ratios · 3 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CCAQ stock.
Collective Acquisition Corp.'s current P/E ratio is 41.1x. The historical average is 60.1x.
Collective Acquisition Corp.'s return on equity (ROE) is 4.7%. The historical average is 8.8%.
Based on historical data, Collective Acquisition Corp. is trading at a P/E of 41.1x. Compare with industry peers and growth rates for a complete picture.
Key Metrics
Top Statement Risk
Trust-dependent income and shell structure
Metrics are mathematically derived from official filings.
Trust-Based Multiples Lack Banking Meaning
Based on IPOD's reported figures, the price of $10.66 and trailing P/E of 48.45 reflect a shell entity whose book value is driven by trust account balances rather than a lending franchise, so conventional bank multiples offer limited insight here. Forward P/E and P/B are unavailable in the supplied data.
The reported tangible book value per share has moved from $7.56 in 2022Q2 to $9.98 in 2026Q2, which appears to reflect trust mechanics and redemption activity rather than earnings growth. Investors should monitor whether the trailing P/E of 48.45 is supported by recurring income, since the operating line was negative in the most recent quarter.
ROE Swings Driven by Non-Operating Items
As reported in financial statements, IPOD's ROE moved from 8.6% in 2022Q1 to 0.3% in 2026Q2, but the DuPont drivers are not comparable to a bank because the entity has no traditional loan book generating a spread.
ROA of 0.2% in 2026Q2 and 0.5% in 2026Q1 combined with a negative operating income of -$960.8K suggests the positive bottom line relies on trust-related or other non-operating entries. The leverage component is distorted by an equity-to-assets ratio of 0.95 that reflects trust structure, so ROE decomposition should be treated as analytically limited.
NIM Reflects Trust Yield, Not Lending Spread
Based on reported figures, IPOD's NIM of 0.9% in 2026Q1 and 2026Q2 against -1.6% in 2025Q4 reflects trust account yields relative to a nominal base, and the efficiency ratio is unavailable in the supplied data.
A NIM of this scale does not represent a funding-cost advantage or asset-yield risk in the way it would for a deposit-taking bank, and the sign reversal in 2025Q4 suggests sensitivity to trust income timing rather than operating performance. Efficiency analysis cannot be meaningfully performed without reported operating expense data for the entity.
Equity Ratios Disconnected From Regulatory Capital
According to reported SEC-style balance sheet figures, IPOD's equity-to-assets ratio of 0.95 in 2026Q2 contrasts with -0.04 across 2025, and CET1, Tier 1, and total capital ratios are not applicable or unavailable in the supplied data.
The swing in equity-to-assets reflects changes in trust-held assets and redemption-linked liabilities rather than retained earnings or regulatory capital accumulation. Capital return capacity cannot be assessed against regulatory minimums because the entity is not subject to bank capital requirements in the supplied data.
P/B Misapplied to Trust-Held Equity
The ratio most commonly misapplied to IPOD is price-to-book, since reported book value of roughly $9.98 per share is dominated by trust account balances that may be redeemed rather than retained as shareholder equity.
P/B obscures whether the equity base represents durable earning capacity or a temporary trust balance subject to redemption, and a reading near parity can appear cheap or fair without reflecting that risk. Investors may instead consider net income excluding non-operating trust items and the trust-to-equity relationship, though further investigation into the entity's structure is warranted before drawing conclusions.